InnovAge Holding Corp. (INNV)

InnovAge's stock has experienced several notable events in the past six months. The company announced a 15.1% year-over-year increase in revenue for the fiscal first quarter ended September 30, 2025, and a net income of $7.7 million. For fiscal year 2025, total revenue increased by approximately 11.8%, but the company reported a net loss of $35.3 million. Analyst ratings have varied, with JPMorgan Chase & Co. initiating coverage with an "underweight" rating, Weiss Ratings restating a "sell" rating, Wall Street Zen upgrading InnovAge to a "strong-buy" rating and KeyBanc maintaining its "Hold" rating. Insider trading activity includes the President and COO selling shares and a Member of the Board of Directors making several purchases. InnovAge and Tampa General Hospital announced a new joint venture to expand access to PACE in the Tampa Bay region, and Dr. Paul Taheri was appointed as its Chief Medical Officer.

The provided search results do not contain explicit information regarding demand seasonality for InnovAge Holding Corp.'s products and services. However, the company's focus on providing care for seniors through the PACE program suggests a relatively stable demand driven by the aging population and ongoing healthcare needs rather than significant seasonal fluctuations. The company has reported consistent participant growth.

InnovAge Holding Corp. is a healthcare delivery platform focused on providing all-inclusive care to dual-eligible seniors through its PACE model, enabling them to live independently. The company operates in the Medical Care Facilities and Services industry, offering a comprehensive range of medical and ancillary services, including in-home care, in-center services, transportation, and care management.

InnovAge operates PACE centers across several states in the United States, including Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers. The company is headquartered in Denver, Colorado.

InnovAge has maintained a positive aspect of its brand reputation by being recertified as a "Great Place to Work" in May 2025 and emphasizes its mission to help seniors live healthier, happier, and more independent lives. However, InnovAge has faced regulatory scrutiny in the past, including a civil investigative demand from the Department of Justice (DOJ) under the Federal False Claims Act, highlighting the importance of compliance and quality.

InnovAge Holding Corp. has significant institutional backing, with institutional investors owning 95.03% of the shares. Apax Partners (UK) Ltd. is the largest shareholder, holding 83.54% of the company's shares. Other major institutional owners include T. Rowe Price Investment Management, Inc., Coliseum Capital Management, LLC, BlackRock, Inc., Vanguard Group Inc, Kent Lake PR LLC, PRSVX - T. Rowe Price Small-Cap Value Fund, Inc., Geode Capital Management, Llc, and Welch Capital Partners Llc/ny. Individual ownership accounts for a smaller portion, at 1.62%. TCO Group Holdings, L.P. is also listed as a top shareholder.